Amoxapine Overdose: Case Report and Pharmacokinetic Profile
Open Access
- 1 January 1983
- journal article
- case report
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 20 (1) , 101-105
- https://doi.org/10.3109/15563658308990055
Abstract
Amoxapine (Ascendin®) is a new tricyclic antidepressant marketed by Lederle Laboratories. Chemically, amoxapine resembles the neuroleptic loxapine, while pharmacologically, amoxapine is similar to imipramine [1]. The following case report describes the clinical presentation and management of an acute amoxapine intoxication.Keywords
This publication has 7 references indexed in Scilit:
- Amoxapine — An Antidepressant With Some Neuroleptic Properties?: A Review of Its Chemistry, Animal Pharmacology and Toxicology, Human Pharmacology, and Clinical EfficacyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1981
- Watch in the StomachJAMA, 1981
- Asystole complicating physostigmine treatment of tricyclic antidepressant overdoseAnnals of Emergency Medicine, 1980
- Tricyclic OverdoseJAMA, 1980
- Tricyclic antidepressant overdoseJournal of the American College of Emergency Physicians, 1979
- Physostigmine Salicylate in the Treatment of Tricyclic Antidepressant OverdosagePublished by American Medical Association (AMA) ,1975
- Acute Poisoning by Tricyclic Antidepressants: Clinical Features and Management of 100 PatientsClinical Toxicology, 1969